Filing Details

Accession Number:
0001209191-22-054850
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-28 17:52:48
Reporting Period:
2022-10-26
Accepted Time:
2022-10-28 17:52:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
708818 Nextgen Healthcare Inc. NXGN Services-Computer Integrated Systems Design (7373) 952888568
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664295 A David Metcalfe 18111 Von Karman Avenue
Suite 600
Irvine CA 92612
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-26 32,372 $14.20 181,148 No 4 M Direct
Common Stock Disposition 2022-10-26 32,372 $20.21 148,776 No 4 S Direct
Common Stock Disposition 2022-10-27 6,091 $19.02 142,685 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-10-26 32,372 $0.00 32,372 $14.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
117,628 2024-02-01 No 4 M Direct
Footnotes
  1. Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.415. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
  3. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock.
  4. Original grant of 200,000 options granted on 2/1/2016 vested in four equal, annual installments beginning 2/1/2017.